Breaking News, Collaborations & Alliances

Be The Match BioTherapies, Atara Biotherapeutics Ink Multi-Year Partnership Extension

Be The Match to provide donor cells in support of Atara’s allogeneic T-cell platform.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Be The Match BioTherapies and Atara Biotherapeutics have extended their collaboration to provide high-quality healthy donor cells for Atara’s off-the-shelf T-cell immunotherapy platform for patients with cancer and autoimmune diseases.   This multi-year partnership leverages the capabilities of Be The Match BioTherapies to source healthy donor cells from the Be The Match Registry with over 22 million genetically diverse human leukocyte antigen (HLA) immune profiles.   “Atara and Be The Match...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters